• P = Professional
  • B = Behavioral health
  • F = Facilities

Farmacia

P B F
1 nov, 2021
Effective 1 de enero de 2022, Prime will begin to mail correspondences to the prescribers primary pract...
P B F
1 nov, 2021
Non-Specialty Pharmacy A new preferred home delivery pharmacy and/or a new option for certain membe...
P B F
1 oct, 2021
The formulary changes noted below are effective as of 1 de octubre de 2021 and apply to all commercial BC...
P F
1 ago, 2021
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P B F
1 jul, 2021
The information below is effective 1 de julio de 2021 and applies only to the individual market segment in...
P B F
1 jul, 2021
The information below is effective 1 de julio de 2021 and applies to all commercial employer groups that a...
P F
1 jun, 2021
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P B F
1 abr, 2021
The information below is effective as of 1 de abril de 2021 and applies to all commercial BCBSRI products...
P F
1 abr, 2021
The following Commercial MDR drugs will require step therapy through a biosimilar effective 4/1/21: ...
P
1 mar, 2021
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P B F
1 ago, 2020
BCBSRI offers home delivery option or an extended supply network pharmacy for new prescriptions or r...
P F
1 ago, 2020
The following codes are being added to Medicare MDR with a 10/1/20 effective date (effective 10/1/20...
P F
1 jun, 2020
Due to the COVID-19 pandemic, BCBSRI has extended all clinical authorization approvals by Prime Ther...
P F
1 de mayo de 2020
Effective 1 de mayo de 2020, Lifespan employee group will begin covering medical specialty drugs under the...
P F
1 de mayo de 2020
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
1 dic, 2019
As part of the annual formulary development and management process, the next scheduled update of the...
P B F
1 oct, 2019
As part of our standard formulary management process of implementing formulary updates twice per yea...
P F
1 oct, 2019
Effective 1 de diciembre de 2019, BCBSRI will begin requiring prior authorization for an expanded list of ...
P F
1 ago, 2019
As of 1 de octubre de 2019, for commercial members, the drugs listed below will move from the specialty p...
P
1 ago, 2019
Effective 1 de julio de 2019, both PCSK-9 products for cholesterol management—Repatha and Praluent—became ...
P
1 de mayo de 2019
Pharmacy benefit coverage for Commercial members will be updated effective 1 de mayo de 2019 to include co...
P
1 abr, 2019
The BCBSRI Commercial formulary for April is now available. You can view the summary that provides d...
P
1 mar, 2019
Consistent with our management practice, 1 de abril de 2019 is the next scheduled update of the BCBSRI Co...
P
1 mar, 2019
Effective 1 de abril de 2019, coverage of Radicava will change from the specialty pharmacy benefit to the...